AI-based Revero offers personalized care through an online platform that connects physicians with users. It uses nutritional therapy and expert knowledge with machine learning and digital tools to treat chronic conditions.
The company addresses a number of chronic conditions including diabetes, arthritis, psoriasis, and irritable bowel syndrome and plans to extend to other conditions such as type-2 diabetes, heart disease, and mental health issues. After the initial virtual screening by a doctor, members will be provided with nutrition and treatment plans ranging 1–12 months.
As of July 2023, the company was yet to launch its virtual clinic and had plans to operate a B2B2C business model, offering services via employers, insurance providers, and individuals on a subscription basis. As of November 2022, Revero had 3,000 members.
Funding and Financials
Revero raised USD 5 million in November 2022 via a seed funding round with participation from A16Z Scout, Goodwater Capital, Think+ Ventures, and CapitalX. The new funds were used to expand its market reach across the US and further extend the number of chronic conditions it covers. It has achieved a 56% compound growth rate and more than USD 0.5 million in annual revenue since its launch in 2019.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.